Canada markets closed

Vivoryon Therapeutics N.V. (05Y.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.7830+0.0770 (+10.91%)
At close: 12:18PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
-3,620
-3,620
0
10,764
0
Cost of Revenue
-525
-525
0
1,569
0
Gross Profit
-3,095
-3,095
0
9,196
0
Operating Expenses
Research Development
17,637
17,637
20,224
17,452
13,210
Selling General and Administrative
3,272
3,272
4,898
2,354
1,523
Total Operating Expenses
25,700
25,700
29,059
22,094
16,011
Operating Income or Loss
-28,795
-28,795
-29,059
-12,898
-16,011
Interest Expense
56
56
24
24
23
Income Before Tax
-28,576
-28,576
-28,355
-12,223
-16,510
Income Tax Expense
-234
-234
-199
432
0
Income from Continuing Operations
-28,342
-28,342
-28,156
-12,655
-16,510
Net Income
-28,342
-28,342
-28,156
-12,655
-16,510
Net Income available to common shareholders
-28,342
-28,342
-28,156
-12,655
-16,510
Basic EPS
-1.12
-1.12
-1.28
-0.63
-0.83
Diluted EPS
-1.12
-1.12
-1.28
-0.63
-0.83
Basic Average Shares
23,711
25,242
22,020
20,000
19,975
Diluted Average Shares
23,711
25,242
22,020
20,000
19,975